Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort
Comparison of outcomes between laparoscopic <i>vs.</i> open liver resection for intermediate stage hepatocellular carcinoma
Hepatocellular carcinoma in the setting of interferon-free treatment for chronic HCV hepatitis - experience of a single center
Qidong hepatitis B virus infection cohort: a 25-year prospective study in high risk area of primary liver cancer
Treatment of high-burden hepatocellular carcinoma: an oncologist perspective
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum
Congenital absence of the portal vein complicated by hepatocellular carcinoma in the liver of an adult woman: review of imaging, literature and management
Prediction of post-progression survival in patients with advanced hepatocellular carcinoma treated with sorafenib by using time-dependent changes in clinical characteristics
Lycopene treatment stalls the onset of experimentally induced hepatocellular carcinoma: a radioisotopic, physiological and biochemical analysis
Systemic therapies for hepatocellular carcinoma: a recap of the current status
A potential clinical based score in hepatitis C virus cirrhotic patients to exclude small hepatocellular carcinoma
Beta2-glycoprotein I cooperate with hepatitis B surface antigen promotes hepatocellular carcinogenesis via the nuclear factor kappa B signal pathway were enhanced by the lipopolysaccharide
Neoadjuvant hepatic arterial infusion chemotherapy for resectable hepatocellular carcinomas
New strategy to distinguish clonal origin of RHCC/MHCC between intrahepatic metastasis and multicentric occurrence
Hepatocellular carcinoma in patients without cirrhosis: relevance and clinical characteristics
T cell immunotherapy in hepatitis B virus related hepatocellular carcinoma
Pre-S2 and HBV associated hepatocellular carcinoma
Ablative techniques in hepatocellular carcinoma treatment
Mitoepigenetics and hepatocellular carcinoma
Intrahepatic cholangiocarcinoma: review and update
Pathway analysis provides insight into the genetic susceptibility to hepatocellular carcinoma and insight into immuno-therapy treatment response
Time for hepatocellular carcinoma immunotherapy: insights for successful clinical applications in this challenging tumor
Molecular targeting of antiviral drugs used against hepatitis C virus infection
Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries
HCV clearance by direct antiviral therapy and occurrence/recurrence of hepatocellular carcinoma: still an issue?
Expression quantitative trait loci for <i>PVT1</i> contributes to the prognosis of hepatocellular carcinoma
Pro-oncogenic role of SerpinB3 in hepatocellular carcinoma
Hypoxic microenvironment and hepatocellular carcinoma treatment
Understanding the inflammation-cancer transformation in the development of primary liver cancer
Oncogenic Wnt3a: a promising specific biomarker in hepatocellular carcinoma
Performance of different biomarkers for the management of hepatocellular carcinoma
The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma
Living donor liver transplantation for patients with hepatocellular carcinoma in Japan
Somatostatin in hepatocellular carcinoma: experimental and therapeutic implications
[<sup>18</sup>F]FDG PET imaging evaluation on non-alcoholic fatty liver disease and hepatocellular carcinoma model treated with sorafenib
Aberrant pre-mRNA splicing regulation in the development of hepatocellular carcinoma
Hepatitis C related hepatocellular carcinoma in the era of direct-acting antivirals
Fat and hepatocellular carcinoma
Oxidative stress and hepatocarcinogenesis
Immunotherapy: a new era for hepatocellular carcinoma
Heat shock reduces HCV replication via regulation of ribosomal L22 in Alu-RNA molecule dependent manner
Molecular mechanism of hepatocellular carcinoma
Factors predicting hepatocellular carcinoma in hepatitis C infection
Exosome-based liquid biopsy in the management of hepatocellular carcinoma
Elimination of hepatitis from Pakistan by 2030: is it possible?
Screening for hepatocellular carcinoma: summary of current guidelines up to 2018
Laparoscopic liver resection for hepatocellular carcinoma
Chitinase-3-like protein 1 as a predictor for the progression or regression of liver fibrosis
Hypofractionated ablative radiation therapy for hepatocellular carcinoma: practical considerations and review of the literature
Hepatic resection for hepatocellular carcinoma
Cancer immunotherapy for hepatocellular carcinoma
The fibroblast growth factor receptor pathway in hepatocellular carcinoma
Thermal ablation of large unresectable hepatocellular carcinoma in cirrhotic patients
Adult African Americans undergoing cadaveric liver transplantation for hepatocellular carcinoma within the Milan criteria have the lowest 5-year survival among all the ethnic groups in the United States: analysis of USA national data between January 2002
Mechanisms and clinical behavior of hepatocellular carcinoma in HBV and HCV infection and alcoholic and non-alcoholic fatty liver disease
HCV-discovery to elimination, “myth or reality”
New insights on hepatocellular carcinoma: epidemiology and clinical aspects
Staging of hepatocellular carcinoma
Role of the contrast-enhanced ultrasoud in the diagnosis of HCC in cirrhotic liver
Liver transplantation for hepatocellular carcinoma - non-cancer factors and implications for improving outcome beyond standard tumor criteria
Novel diagnosis and therapy for hepatoma targeting HBV-related carcinogenesis through alternative splicing of FIR (PUF60)/FIRΔexon2
Quantitative hepatitis B surface antigen in predicting recurrence of hepatitis B-related hepatocellular carcinoma after liver transplantation
Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver transplantation
HCV elimination: breaking down the barriers to prison based care
New and old biomarkers of hepatocellular carcinoma
Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation
Endolymphatic immunotherapy for advanced hepatocellular carcinoma: an update of our experience
Minimally invasive therapies for hepatocellular carcinoma: narrowing the gaps
Stemness features in liver cancer
Direct-acting antivirals and hepatocellular carcinoma occurrence and recurrence in hepatitis C virus-related liver cirrhosis: fact or fiction
Efficacy and safety of generic daclatasvir + sofosbuvir ± ribavirin in treatment of genotype 3 infected hepatitis C patients - a real life experience from Pakistan
Simple screening method for the diagnosis of nonB-nonC hepatocellular carcinoma
Surveillance for hepatocellular carcinoma - current status and advances
Direct-acting antivirals and chronic hepatitis C: towards elimination
The prediction of microvascular invasion of hepatocellular carcinoma using multiple imaging modalities